logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

TNBC: adding atezolizumab to chemo ups survival in IMpassion130

Atezolizumab is the first checkpoint inhibitor to reach phase 3 in breast cancer trials.